|
GB8427125D0
(en)
|
1984-10-26 |
1984-12-05 |
Lundbeck & Co As H |
Organic compounds
|
|
HU198005B
(en)
|
1984-12-04 |
1989-07-28 |
Sandoz Ag |
Process for producing mevqlolakton, derivatives, its indene-analogues and pharmaceutical compositions containing them
|
|
DK286990D0
(da)
*
|
1990-12-04 |
1990-12-04 |
Lundbeck & Co As H |
Indanderivater
|
|
DK55192D0
(da)
|
1992-04-28 |
1992-04-28 |
Lundbeck & Co As H |
1-piperazino-1,2-dihydroindenderivater
|
|
US6221335B1
(en)
|
1994-03-25 |
2001-04-24 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
KR100477070B1
(ko)
|
1994-03-25 |
2006-04-21 |
이소테크니카 인코포레이티드 |
중수소화작용에의한의약품의효능강화법
|
|
JP2001517666A
(ja)
|
1997-09-23 |
2001-10-09 |
藤沢薬品工業株式会社 |
チアゾール誘導体
|
|
US6350786B1
(en)
|
1998-09-22 |
2002-02-26 |
Hoffmann-La Roche Inc. |
Stable complexes of poorly soluble compounds in ionic polymers
|
|
SE9904850D0
(sv)
|
1999-12-30 |
1999-12-30 |
Pharmacia & Upjohn Ab |
Novel process and intermediates
|
|
CA2536073A1
(en)
|
2003-08-18 |
2005-02-24 |
H. Lundbeck A/S |
Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
|
|
CA2569843A1
(en)
|
2004-06-08 |
2005-12-22 |
A. Carlsson Research Ab |
New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
|
|
RU2366654C2
(ru)
|
2004-06-08 |
2009-09-10 |
ЭнЭсЭйБи, ФИЛИАЛ АФ НЕУРОСЕРЧ СВИДЕН АБ, СВЕРИЙЕ |
Новые дизамещенные фенилпиперидины/пиперазины в качестве модуляторов допаминовой нейротрансмиссии
|
|
TWI453198B
(zh)
|
2005-02-16 |
2014-09-21 |
Lundbeck & Co As H |
製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s)-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法
|
|
JP2008530039A
(ja)
|
2005-02-16 |
2008-08-07 |
ハー・ルンドベック・アクチエゼルスカベット |
トランス−1−((1r,3s)−6−クロロ−3−フェニルインダン−1−イル)−3,3−ジメチルピペラジンの酒石酸塩およびリンゴ酸塩
|
|
TWI376373B
(en)
|
2005-02-16 |
2012-11-11 |
Lundbeck & Co As H |
Crystalline base of a pharmaceutical compound
|
|
US7863274B2
(en)
|
2005-07-29 |
2011-01-04 |
Concert Pharmaceuticals Inc. |
Deuterium enriched analogues of tadalafil as PDE5 inhibitors
|
|
CN101273024A
(zh)
|
2005-07-29 |
2008-09-24 |
康瑟特制药公司 |
新颖苯并[d][1,3]-二氧杂环戊烯衍生物
|
|
EP2998288B1
(en)
|
2005-12-01 |
2022-08-24 |
ACADIA Pharmaceuticals Inc. |
Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
|
|
WO2008086158A1
(en)
|
2007-01-04 |
2008-07-17 |
Smithkline Beecham Corporation |
Benzodihydroquinazoline as pi3 kinase inhibitors
|
|
US8198305B2
(en)
|
2007-04-13 |
2012-06-12 |
Concert Pharmaceuticals Inc. |
1,2-benzisoxazol-3-yl compounds
|
|
US7528131B2
(en)
|
2007-04-19 |
2009-05-05 |
Concert Pharmaceuticals Inc. |
Substituted morpholinyl compounds
|
|
EP1997479A1
(en)
|
2007-05-31 |
2008-12-03 |
Helm AG |
Stabilized amorphous candesartan cilexetil compositions for oral administration
|
|
US20090062303A1
(en)
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched ziprasidone
|
|
MX2010012037A
(es)
|
2008-05-07 |
2010-11-30 |
Lundbeck & Co As H |
Composiciones y uso utiles para tratar trastornos cognitivos.
|
|
JP2012504560A
(ja)
|
2008-10-03 |
2012-02-23 |
ハー・ルンドベック・アクチエゼルスカベット |
経口製剤
|
|
EP2362865A2
(en)
|
2008-10-28 |
2011-09-07 |
Concert Pharmaceuticals Inc. |
Deuterated 2-propylpentanoic acid compounds
|
|
JP2012506904A
(ja)
|
2008-10-28 |
2012-03-22 |
エージェンシー フォー サイエンス,テクノロジー アンド リサーチ |
難水溶性成分のためのメソ多孔性材料賦形剤
|
|
TW201102370A
(en)
*
|
2009-07-07 |
2011-01-16 |
Lundbeck & Co As H |
Manufacture of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl piperazine
|
|
US8557994B2
(en)
|
2009-07-27 |
2013-10-15 |
Daljit Singh Dhanoa |
Deuterium-enriched pyridinonecarboxamides and derivatives
|
|
US8658236B2
(en)
|
2009-08-21 |
2014-02-25 |
Deuteria Beverages, Llc |
Alcoholic compositions having a lowered risk of acetaldehydemia
|
|
KR101149529B1
(ko)
|
2009-09-11 |
2012-05-25 |
한국화학연구원 |
인덴온 유도체 및 이를 포함하는 약학적 조성물
|
|
CN102020522A
(zh)
|
2009-09-21 |
2011-04-20 |
陈松源 |
氘代药物的制备方法和应用
|
|
US8278460B2
(en)
|
2009-10-15 |
2012-10-02 |
Concert Pharmaceuticals, Inc. |
Substituted benzimidazoles
|
|
WO2011059080A1
(ja)
|
2009-11-16 |
2011-05-19 |
第一三共株式会社 |
同位体置換されたジアミン誘導体
|
|
EP2521711B1
(en)
|
2010-01-07 |
2017-08-16 |
Alkermes Pharma Ireland Limited |
Quaternary ammonium salt prodrugs
|
|
EP2639216B1
(en)
|
2010-11-09 |
2018-07-11 |
Kaneka Corporation |
Halogenated indenones and method for producing optically active indanones or optically active indanols by using same
|
|
EP2661427A1
(en)
|
2011-01-07 |
2013-11-13 |
H. Lundbeck A/S |
Method for resolution of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1r,3s)-6-chloro-3-phenyl-indan, 1-yl)-3,3-dimethyl-piperazine
|
|
US9359376B2
(en)
|
2011-04-08 |
2016-06-07 |
Sphaera Pharma Pte. Ltd |
Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
|
|
LT3135656T
(lt)
|
2011-06-20 |
2019-04-25 |
H. Lundbeck A/S |
Deuterinti 1-piperazin-3-fenilindanai, skirti šizofrenijos gydymui
|
|
EP2903979B1
(en)
*
|
2012-10-04 |
2020-08-19 |
Inhibikase Therapeutics, Inc. |
Novel compounds, their preparation and their uses
|
|
CA2893256A1
(en)
*
|
2012-12-11 |
2014-06-19 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
|
|
AR094054A1
(es)
|
2012-12-19 |
2015-07-08 |
H Lundbeck As |
6-cloro-3-(fenil-d₅)-inden-1-ona y uso de la misma
|
|
CN112930341A
(zh)
|
2018-10-29 |
2021-06-08 |
H.隆德贝克有限公司 |
无定形的具有式(i)的化合物和无定形的具有式(i)的化合物的盐
|
|
CN113056457B
(zh)
|
2018-12-03 |
2025-06-20 |
H.隆德贝克有限公司 |
用于治疗cns疾病的前药
|